Abstract:Abstract Background Alzheimer’s disease (AD) is a complex pathophysiological disease. Its progression is heterogenous and associated with clinical symptoms as well as prognosis. Hence, understanding the progression of AD is important in guiding patient management, evaluating treatment response and designing therapeutic trials. We developed and validated a novel machine learning model for revealing the underlying disease progression patterns from longitudinal multi-modal data of AD. Methods The prospective ADNI study data (1192 patients with cognitive impairment and 388 healthy controls) was used to train, validate and test a novel personalized hidden Markov model to identify disease-related states. The transition diagram of disease-related states exhibited two distinct disease progression patterns. We used the index of disease-related states as a predictor, and evaluated the prediction performance on time to conversion to AD dementia. External validation was performed on the AIBL cohort (87 patients with cognitive impairment and 179 healthy controls). Findings Our model identified ten biologically and clinically meaningful disease-related states from longitudinal multi-modal data, which constitute three non-overlapping stages (i.e., neocortical atrophy [NCA], medial temporal atrophy [MTA], and whole brain atrophy [WBA]) and two distinct disease progression patterns (i.e., NCA→WBA and MTA→WBA) hidden in the trajectories of AD patients. Disclosed patterns showed different atrophy trends of brain regions, and presented distinct genetic, clinical and biomarker characteristics, especially in the early course of the disease. The index of the identified disease-related states provided a remarkable performance on predicting the time to conversion to AD dementia (C-Index: 0.923±0.007), in comparison with the other commonly recognized AD risk factors, including APOE (0.607±0.012), MMSE score (0.808±0.006), Abeta (0.7445±0.013), pTau (0.689±0.006), and hippocampal volume (0.774±0.010). Interpretation A machine learning algorithm was proposed to capture the full spectrum of AD progression by identifying meaningful AD-related states as well as distinct disease progression patterns from longitudinal multi-modal data, showing its potential for promoting the understanding of heterogeneous disease progression, and early predicting the conversion time to AD dementia.

Learning semi-supervised enrichment of longitudinal imaging-genetic data for improved prediction of cognitive decline

A Novel Cascade Machine Learning Pipeline for Alzheimer’s Disease Identification and Prediction

Predicting Cognitive Declines Using Longitudinally Enriched Representations For Imaging Biomarkers

High-Order Multi-Task Feature Learning to Identify Longitudinal Phenotypic Markers for Alzheimer's Disease Progression Prediction.

Integrating Static and Dynamic Data for Improved Prediction of Cognitive Declines Using Augmented Genotype-Phenotype Representations.

Longitudinal Genotype-Phenotype Association Study Via Temporal Structure Auto-learning Predictive Model

Towards Multimodal Longitudinal Analysis for Predicting Cognitive Decline Using Neuroimaging Biomarkers, Cognitive Assessments, and Demographic Data

Integrating Genetic Information for Early Alzheimer’s Diagnosis through MRI Interpretation

Multi-modal Sequence Learning for Alzheimer's Disease Progression Prediction with Incomplete Variable-Length Longitudinal Data.

Machine learning on longitudinal multi-modal data enables the understanding and prognosis of Alzheimer's disease progression

Prediction of cognitive decline for enrichment of Alzheimer's disease clinical trials

Integrating Convolutional Neural Networks and Multi-Task Dictionary Learning for Cognitive Decline Prediction with Longitudinal Images

Attention-guided 3D CNN With Lesion Feature Selection for Early Alzheimer's Disease Prediction Using Longitudinal sMRI

Early prediction of Alzheimer’s disease using longitudinal volumetric MRI data from ADNI

Long Range Early Diagnosis of Alzheimer's Disease Using Longitudinal MR Imaging Data

Machine Learning Based Multimodal Neuroimaging Genomics Dementia Score for Predicting Future Conversion to Alzheimer's Disease

Multi-modal sequence learning for Alzheimer’s disease progression prediction with incomplete variable-length longitudinal data

Machine learning on longitudinal multi-modal data enabling the understanding and prognosis of Alzheimer’s disease progression

Learning the progression and clinical subtypes of Alzheimer's disease from longitudinal clinical data

Deep Geometric Learning with Monotonicity Constraints for Alzheimer's Disease Progression

A Machine Learning Approach for Predicting Deterioration in Alzheimer's Disease